Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation

J. Douglas Rizzo, John R. Wingard, Andre Tichelli, Stephanie J. Lee, Maria Teresa Van Lint, Linda J. Burns, Stella M. Davies, James L M Ferrara, Gérard Socié

Research output: Contribution to journalArticle

Abstract

More than 40 000 hematopoietic cell transplants (HCTs) are performed worldwide each year. With improvements in transplant technology, larger numbers of transplant recipients survive free of the disease for which they were transplanted. However, there are late complications that can cause substantial morbidity. Many survivors are no longer under the care of transplant centers, and many community health care providers may be unfamiliar with health matters relevant to HCT. The Center for International Blood and Marrow Transplant Research (CIBMTR), European Group for Blood and Marrow Transplantation (EBMT), and American Society for Bone Marrow Transplantation (ASBMT) have developed these recommendations to offer care providers suggested screening and prevention practices for autologous and allogeneic HCT survivors.

Original languageEnglish
Pages (from-to)138-151
Number of pages14
JournalBiology of Blood and Marrow Transplantation
Volume12
Issue number2
DOIs
Publication statusPublished - Feb 2006

    Fingerprint

Keywords

  • HCT (hematopoietic cell transplantation)
  • Late effects
  • Prevention
  • Screening

ASJC Scopus subject areas

  • Transplantation

Cite this